Clinical Trial Update: Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rituximab to calcineurin inhibitors in children with steroid-resistant nephrotic syndrome, focusing on efficacy and safety; status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Nilratan Sircar Medical College | Conditions: Nephrotic Syndrome | Phase 4 | Status: UNKNOWN